Industrial perspective of gastroretentive drug delivery systems: Physicochemical, biopharmaceutical, technological and regulatory consideration

Expert Opinion on Drug Delivery

Volumn 9, Issue 5, 2012, Pages 551-565

  Pawar, Vivek K ^a   Kansal, Shaswat ^a   Asthana, Shalini ^a   Chourasia, Manish K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

analytical specifications; dual working systems; gastroretentive drug delivery systems; in vitroin vivo correlation; preformulation studies; scale up

Indexed keywords

ACICLOVIR; ALFUZOSIN; ATENOLOL; CAPTOPRIL; CEFACLOR; CEFALEXIN; CIPROFLOXACIN; DIPYRIDAMOLE; DOMPERIDONE; EXCIPIENT; FERROUS SULFATE; FUROSEMIDE; GABAPENTIN; ITRACONAZOLE; METFORMIN; METOPROLOL SUCCINATE; NORFLOXACIN; OFLOXACIN; PRAZOSIN; RANITIDINE; REPAGLINIDE; RIFAXIMIN; SILYMARIN; SIMETHICONE; TACROLIMUS; TRIMETAZIDINE; UNINDEXED DRUG; VALACICLOVIR; VERAPAMIL; ZOLPIDEM TARTRATE;

BIOEQUIVALENCE; COST EFFECTIVENESS ANALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MARKETING; DRUG METABOLISM; DRUG PENETRATION; DRUG QUALITY; DRUG SOLUBILITY; GASTRORETENTIVE DRUG DELIVERY SYSTEM; HUMAN; HYDROPHOBICITY; MAXIMUM PLASMA CONCENTRATION; PHARMACODYNAMICS; REVIEW; SCALE UP; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION PROCESS;

BIOLOGICAL AGENTS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUGS, GENERIC; DUODENUM; EXCIPIENTS; HUMANS; INTESTINAL ABSORPTION; JEJUNUM; PHARMACEUTICAL PREPARATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; STOMACH; TECHNOLOGY, PHARMACEUTICAL;

EID: 84859968491     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.677431     Document Type: Review

References (108)

1. Stanley SD. Formulation strategies for absorption windows. Drug Discov Today 2005;10(4):249-57
2. Prinderre P, Sauzet C, Fuxen C. Advances in gastro retentive drug-delivery systems. Expert Opin Drug Deliv 2011;8(9):1189-203
3. Waugh A, Grant A. Ross and Wilson Anatomy and Physiology in Health and Illness. Elsevier Churchill Livingstone; Edinburgh, UK: 2010
4. Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv 2006;3(2):217-33 (Pubitemid 43338093)
5. Bardonnet PL, Faivre V, Pugh WJ, et al. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J Control Release 2006;111(1-2):1-18 (Pubitemid 43289989)
6. Adibkia K, Hamedeyazdan S, Javadzadeh Y. Drug release kinetics and physicochemical characteristics of floating drug delivery systems. Expert Opin Drug Deliv 2011;8(7):891-903
7. Chawla G, Gupta P, Koradia V, Bansal AK. Gastroretention a means to address regional variability in intestinal drug absorption. Pharm Technol 2003;July:52-68
8. Pawar VK, Kansal S, Garg G, et al. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems. Drug Deliv 2011;18(2):97-110
9. Mostafavi A, Emami J, Varshosaz J, et al. Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: Pharmacokinetic characterization in healthy human volunteers. Int J Pharm 2011;409(1-2):128-36
10. Chavanpatil M, Jain P, Chaudhari S, et al. Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. Int J Pharm 2005;304(1-2):178-84 (Pubitemid 41427660)
11. Hu L, Li L, Yang X, et al. Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: In vitro and in vivo evaluation in healthy volunteers. Eur J Pharm Sci 2011;42(1-2):99-105
12. Ali J, Arora S, Ahuja A, et al. Formulation and development of hydrodynamically balanced system for metformin: In vitro and in vivo evaluation. Eur J Pharm. Biopharm. 2007;67(1):196-201 (Pubitemid 46991323)
13. Baki G, Bajdik J, Pintye-Hodi K. Evaluation of powder mixtures and hydrophilic gastroretentive drug delivery systems containing zinc acetate and sodium bicarbonate. J Pharm Biomed Anal 2011;54(4):711-16
14. Yao H, Xu L, Han F, et al. A novel riboflavin gastro-mucoadhesive delivery system based on ion-exchange fiber. Int J Pharm 2008;364(1):21-6
15. Rajinikanth PS, Mishra B. Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori. J Control Release 2008;125(1):33-41 (Pubitemid 350198674)
16. Gisbert JP, Torrado S, M de la Torre P, et al. Amoxicillin gastric retention systems for Helicobacter pylori treatment. Gastroenterology 2011;140(5 Suppl 1):S-880
17. Jang SW, Lee JW, Park SH, et al. Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis. Int J Pharm 2008;356(1-2):88-94
18. Guan J, Zhou L, Nie S, et al. A novel gastric-resident osmotic pump tablet: In vitro and in vivo evaluation. Int J Pharm 2010;383(1-2):30-6
19. Jimenez-Martinez I, Quirino-Barreda T, Villafuerte-Robles L. Sustained delivery of captopril from floating matrix tablets. Int J Pharm 2008;362(1-2):37-43
20. Kavimandan NJ, Lakshman JP, Matharu AS, et al. Extended release gastro-retentive oral drug delivery system for valsartan. EP2061438; 2009
21. Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 2007;59:828-51 (Pubitemid 47542291)
22. Roy P, Shahiwala A. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough. Eur J Pharm Sci 2009;37:363-9
23. Talukder R, Fassihi R. Gastroretentive delivery systems: A mini review. Drug Dev Ind Pharm 2004;30(10):1019-28 (Pubitemid 39577994)
24. Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol 2006;6(5):501-8 (Pubitemid 44340666)
25. Murphy CS, Pillay V, Choonara YE, du Toit LC. Gastroretentive drug delivery systems: Current developments in novel system design and evaluation. Curr Drug Deliv 2009;6(5):451-60
26. Simoni P, Cerrb C, Cipolla A, et al. Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation. Pharmacol Res 1995;31(2):115-19
27. Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage forms. J Control Release 2003;90(2):143-62 (Pubitemid 36700451)
28. Pund S, Joshi A, Vasu K, et al. Gastroretentive delivery of rifampicin: In vitro mucoadhesion and in vivo gamma scintigraphy. Int J Pharm 2011;411(1-2):106-12
29. Bajpai SK, Bajpai M, Sharma L. Investigation of water uptake behavior and mechanical properties of superporous hydrogels. J Macromol Sci A 2006;43(3):507-24
30. Groning R, Berntgen M, Georgarakis M. Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur J Pharm. Biopharm. 1998;46(3):285-91 (Pubitemid 29057675)
31. Arora S, Ali J, Ahuja A, et al. Floating drug delivery systems: A review. AAPS PharmSciTech 2005;6(3):E372-E90
32. Singh BN, Kim KH. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release 2000;63(3):235-59
33. Soppimath KS, Kulkarni AR, Rudzinski WE, Aminabhavi TM. Microspheres as floating drug delivery systems to increase gastric retention of drugs. Drug Metab Rev 2001;33(2):149-60 (Pubitemid 32703254)
34. Adebisi A, Conway BR. Gastroretentive microparticles for drug delivery applications. J Microencapsul 2011;28(8):689-708
35. Kagan L, Hoffman A. Systems for region selective drug delivery in the gastrointestinal tract: Biopharmaceutical considerations. Expert Opin Drug Deliv 2008;5(6):681-92 (Pubitemid 351998257)
36. Cavalla D. Apt drug R&D: The right active ingredient in the right presentation for the right therapeutic use. Nat Rev Drug Discov 2009;8(11):849-53
37. Kagan L, Hoffman A. Selection of drug candidates for gastroretentive dosage forms: Pharmacokinetics following continuous intragastric mode of administration in a rat model. Eur J Pharm. Biopharm. 2008;69(1):238-46
38. Strubing S, Metz H, Mader K. Characterization of poly(vinyl acetate) based floating matrix tablets. J Control Release 2008;126(2):149-55
39. Jagdale S, Agavekar A, Pandya S, et al. Formulation and evaluation of gastroretentive drug delivery system of propranolol hydrochloride. AAPS PharmSciTech 2009;10(3):1071-9
40. Inactive ingredient search for approved drug products. Office of generic drugs, division of labeling and program support. FDA center for drug evaluation and research, 2011. Available from: Http://www.Accessdata.Fda.Gov/scripts/cder/ iig/index.Cfm [Last accessed 23 November 2011]
41. Nur AO, Zhang JS. Recent progress in sustained/controlled oral delivery of captopril: An overview. Int J Pharm 2000;194(2):139-46 (Pubitemid 30110676)
42. Meka L, Kesavan B, Chinnala K, et al. Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: In vitro evaluation. AAPS PharmSciTech 2008;9(2):612-19
43. Patel P, Dand N, Somwanshi A, et al. Design and evaluation of a sustained release gastroretentive dosage form of captopril: A technical note. AAPS PharmSciTech 2008;9(3):836-9
44. Madgulkar A, Kadam S, Pokharkar V. Studies on formulation development of mucoadhesive sustained release itraconazole tablet using response surface methodology. AAPS PharmSciTech 2008;9(3):998-1005
45. Kerc J. Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor. US7642287; 2010
46. Kerc J, Salobir M, Bavec S. Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium. US7030151; 2006
47. Khan F, Dehghan M. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation. AAPS PharmSciTech 2011;12(4):1077-86
48. Chandavarkar MA, Chand JK, Malayandi R. A novel oral controlled release dosage forms for water soluble drugs. WO2010100657; 2010
49. Liu Y, Zhang J, Gao Y, Zhu J. Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. Int J Pharm 2011;413(1-2):103-9
50. Sahasathian T, Praphairaksit N, Muangsin N. Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin. Arch Pharm Res 2010;33(6):889-99
51. Zheng J, Liu C, Bao D, et al. Preparation and evaluation of floating-bioadhesive microparticles containing clarithromycin for the eradication of Helicobacter pylori. J Appl Polym Sci 2006;102(3):2226-32 (Pubitemid 44619596)
52. Chavanpatil MD, Jain P, Chaudhari S, et al. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 2006;316(1-2):86-92 (Pubitemid 43765689)
53. Mina Ibrahim T. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: Development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm. Biopharm. 2010;74(2):332-9
54. Varshosaz J, Tavakoli N, Roozbahani F. Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Deliv 2006;13(4):277-85 (Pubitemid 43739139)
55. Umamaheshwari RB, Jain S, Jain NK. A new approach in gastroretentive drug delivery system using cholestyramine. Drug Deliv 2003;10(3):151-60 (Pubitemid 36993366)
56. Umamaheswari RB, Jain S, Tripathi PK, et al. Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori. Drug Deliv 2002;9(4):223-31 (Pubitemid 35397024)
57. Dudhara KM, Dharmadhikari NB, Dhavse VV. Gastric retention controlled drug delivery system. US7776345; 2010
58. Berner B, Cowles VE. Case studies in swelling polymeric gastric retentive tablets. Expert Opin Drug Deliv 2006;3(4):541-8
59. Chen RN, Ho HO, Yu CY, Sheu MT. Development of swelling/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism. Eur J Pharm Sci 2010;39(1-3):82-9
60. Arza R, Gonugunta C, Veerareddy P. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech 2009;10(1):220-6
61. ICH Q6A specifications: Test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances. International conference on harmonization, 1999. Available from: Http://www.Ich.Org/products/ guidelines/quality/quality-single/article/specifications-test-procedures- Andacceptance-criteria-for-new-drugsubstances-And-new-drug-produc.Html [Last accessed 5 November 2011]
62. ICH Q2 (R1) validation of analytical procedures: Text and methodology. International conference on harmonization, 1996. Available from: Http://www.Ich.Org/products/guidelines/quality/quality-single/article/ validation-ofanalytical-procedures-text-Andmethodology. Html [Last accessed 5 November 2011]
63. Laulicht B, Cheifetz P, Tripathi A, Mathiowitz E. Are in vivo gastric bioadhesive forces accurately reflected by in vitro experiments? J Control Release 2009;134(2):103-10
64. Parikh DC, Amin AF. In vitro and in vivo techniques to assess the performance of gastro-retentive drug delivery systems: A review. Expert Opin Drug Deliv 2008;5(9):951-65
65. Good manufacturing practice (GMP) guidelines/inspection checklist. United states food & drug administration, 2009. Available from: Http://www.Fda.Gov/cosmetics/guidancecomplian ceregulatoryinformation/ goodmanufacturingpracticegmpguideline sinspectionchecklist/default.Htm Last accessed 15 November 2011]
66. Varshosaz J, Tabbakhian M, Zahrooni M. Development and characterization of floating microballoons for oral delivery of cinnarizine by a factorial design. J Microencapsul 2007;24(3):253-62 (Pubitemid 46567408)
67. Narkar M, Sher P, Pawar A. Stomach-specific controlled release gellan beads of acid-soluble drug prepared by ionotropic gelation method. AAPS PharmSciTech 2010;11(1):267-77
68. Nagarwal R, Srinatha A, Pandit J. In situ forming formulation: Development, evaluation, and optimization using 33 factorial design. AAPS PharmSciTech 2009;10(3):977-84
69. Pal D, Nayak A. Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules. AAPS PharmSciTech 2011;12(4):1431-41
70. Awasthi R, Kulkarni GT, Pawar VK, Garg G. Optimization studies on gastroretentive floating system using response surface methodology. AAPS PharmSciTech 2011;published online 2 December 2011; DOI: 10.1208/s12249-011- 9730-y.
71. Badhan A, Mashru R, Shah P, et al. Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection. AAPS PharmSciTech 2009;10(2):459-67
72. Boldhane S, Kuchekar B. Development and optimization of metoprolol succinate gastroretentive drug delivery system. Acta Pharm 2010;60(4):415-25
73. Miyazaki Y, Yakou S, Yanagawa F, Takayama K. Evaluation and optimization of preparative variables for controlled-release floatable microspheres prepared by poor solvent addition method. Drug Dev Ind Pharm 2008;34(11):1238-45
74. Patel D, Patel N, Pandya N, Jogani P. Gastroretentive drug delivery system of carbamazepine: Formulation optimization using simplex lattice design: A technical note. AAPS PharmSciTech 2007;8(1):E82-6
75. Kamila MM, Mondal N, Ghosh LK, Gupta BK. Multiunit floating drug delivery system of rosiglitazone maleate: Development, characterization, statistical optimization of drug release and in vivo evaluation. AAPS PharmSciTech 2009;10(3):887-99
76. Rajab M, Jouma M, Neubert RH, Dittgen M. Optimization of a metformin effervescent floating tablet containing hydroxypropylmethylcellulose and stearic acid. Pharmazie 2010;65(2):97-101
77. El Gamal SS, Naggar VF, Allam AN. Optimization of acyclovir oral tablets based on gastroretention technology: Factorial design analysis and physicochemical characterization studies. Drug Dev Ind Pharm 2011;37(7):855-67
78. Sultana S, Bhavna Iqbal Z, et al. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm. J Microencapsul 2009;26(5):385-93
79. Vaghani SS, Patel SG, Jivani RR, et al. Design and optimization of a stomach-specific drug delivery system of repaglinide: Application of simplex lattice design. Pharm Dev Technol 2012;17(1):55-65
80. Guidance for Industry SUPAC-IR/MR: Immediate Release and Modified Release Solid Oral Dosage Forms Manufacturing Equipment Addendum Center for Drug Evaluation and Research (CDER), US Department of Health and Human Services, Food and Drug Administration, 1999. Available from: Http://wwwfdagov/downloads/ Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM070637 [Last accessed 25 November 2011]
81. Guidance for Industry Process Validation: General Principles and Practices. Center for Drug Evaluation and Research (CDER), U.S. Department of Health and Human Services, Food and Drug Administration, 2011. Available from: Http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/ Guidances/UCM070336.pdf [Last accessed 25 November 2011]
82. Guideline on the investigation of bioequivalence. Committee for medicinal products for human use (CHMP), European Medicines Agency, 2008. Available from: Http://www.Ema.Europa. Eu/pdfs/human/qwp/140198enrev1.Pdf [Last accessed 2 December 2011]
83. Bioequivalence recommendations for specific products. United states food & drug administration, 2011. Available from: Http://www.Fda.Gov/drugs/ guidance complianceregulatoryinformation/guidances/ucm075207.Htm [Last accessed 2 December 2011]
84. Guidance for industry bioavailability and bioequivalence studies for orally administered drug products- general considerations. Center for drug evaluation and research (CDER), U.S. Department of health and human services, food and drug administration, 2003. Available from: www.Fda.Gov/downloads/drugs/ guidance complianceregulatoryinformation/guidances/ucm070124.Pdf [Last accessed 2 December 2011]
85. Guidance for industry extended release oral dosage forms: Development, evaluation, and application of in vitro/in vivo correlations. Center for drug evaluation and research (CDER), U.S. Department of health and human services, food and drug administration, 1997. Available from: www.Fda.Gov/downloads/drugs/ guidance complianceregulatoryinformation/guidances/ucm070239.Pdf [Last accessed 2 December 2011]
86. Uppoor VR. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations. J Control Release 2001;72(1-3):127-32 (Pubitemid 32522350)
87. Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: Current perspectives. J Control Release 2009;134(2):74-80
88. Zou H, Jiang X, Kong L, Gao S. Design and evaluation of a dry coated drug delivery system with floating-pulsatile release. J Pharm Sci 2008;97(1):263-73
89. Badve SS, Sher P, Korde A, Pawar AP. Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. Eur J Pharm. Biopharm. 2007;65(1):85-93 (Pubitemid 44827695)
90. Meka L, Kesavan B, Kalamata VN, et al. Design and evaluation of polymeric coated minitablets as multiple unit gastroretentive floating drug delivery systems for furosemide. J Pharm Sci 2009;98(6):2122-32
91. Wang YP, Gan Y, Zhang XX. Novel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: In vitro evaluation and in vivo bioavailability test. Acta Pharmacol Sin 2011;32(10):1294-302
92. Nur AO, Zhang JS. Captopril floating and/or bioadhesive tablets: Design and release kinetics. Drug Dev Ind Pharm 2000;26(9):965-9 (Pubitemid 30471042)
93. Kumar P, Singh S, Mishra B. Floating osmotic drug delivery system of ranitidine hydrochloride: Development and evaluation-A technical note. AAPS PharmSciTech 2008;9(2):480-5
94. Rohith G, Sridhar B, Srinatha A. Floating drug delivery of a locally acting H2-Antagonist: An approach using an in situ gelling liquid formulation. Acta Pharm 2009;59(3):345-54
95. Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization. J Control Release 2005;107(2):300-9 (Pubitemid 41316292)
96. Nayak A, Jain SK, Pandey RS. Controlling release of metformin HCl through incorporation into stomach specific floating alginate beads. Mol Pharm 2011;8(6):2273-81
97. Abdelbary A, El-Gazayerly ON, El-Gendy NA, Ali AA. Floating tablet of trimetazidine dihydrochloride: An approach for extended release with zero-order kinetics. AAPS PharmSciTech 2010;11(3):1058-67
98. Srinatha A, Pandit JK. Multi-unit floating alginate system: Effect of additives on ciprofloxacin release. Drug Deliv 2008;15(7):471-6
99. Liu Q, Fassihi R. Zero-order delivery of a highly soluble, low dose drug alfuzosin hydrochloride via gastro-retentive system. Int J Pharm 2008;348(1-2):27-34 (Pubitemid 350278551)
100. Sonani NG, Hiremath SP, Dasankoppa FS, et al. Design and evaluation of gastroretentive mucoadhesive cephalexin tablets. Pharm Dev Technol 2010;15(2):178-83
101. Nayak AK, Das B, Maji R. Gastroretentive hydrodynamically balanced systems of ofloxacin: In vitro evaluation. Saudi Pharm J 2011;published online 22 November 2011; doi:10.1016/j.jsps.2011.11.002.
102. Bomma R, Swamy Naidu R, Yamsani M, Veerabrahma K. Development and evaluation of gastroretentive norfloxacin floating tablets. Acta Pharm 2009;59(2):211-21
103. Garg R, Gupta GD. Preparation and evaluation of gastroretentive floating tablets of silymarin. Chem Pharm Bull 2009;57(6):545-9
104. Tao Y, Lu Y, Sun Y, et al. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability. Int J Pharm 2009;378(1-2):30-6
105. Zhang Z, Peng B, Yang X, et al. Design and evaluation of a novel floating osmotic pump system. J Pharm Pharm Sci 2009;12(1):129-37
106. Patel A, Modasiya M, Shah D, Patel V. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets. AAPS PharmSciTech 2009;10(1):310-15
107. Prajapati S, Patel L, Patel D. Gastric floating matrix tablets: Design and optimization using combination of polymers. Acta Pharm 2008;58(2):221-9
108. Amrutkar PP, Chaudhari PD, Patil SB. Design and in vitro evaluation of multiparticulate floating drug delivery system of zolpidem tartarate. Colloids Surf B Biointerfaces 2012;89:182-7